Gene · 580
Papers4,139
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
841 to 860 of 4,139
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A New SMAD4 Splice Site Variant in a Three-Generation Italian Family with Juvenile Polyposis Syndrome. | Diagnostics (Basel) | 2022 | 36359527 | PubTator, text mining | PubMed |
| The Prognostic and Therapeutic Potential of DNA Damage Repair Pathway Alterations and Homologous Recombination Deficiency in Lung Cancer. | Cancers (Basel) | 2022 | 36358724 | PubTator, text mining | PubMed |
| DNA Repair Mechanisms, Protein Interactions and Therapeutic Targeting of the MRN Complex. | Cancers (Basel) | 2022 | 36358700 | PubTator, text mining | PubMed |
| PARP1 proximity proteomics reveals interaction partners at stressed replication forks. | Nucleic Acids Res | 2022 | 36350633 | PubTator, text mining | PubMed |
| Regulation of BRCA1 stability through the tandem UBX domains of isoleucyl-tRNA synthetase 1. | Nat Commun | 2022 | 36347866 | PubTator, text mining | PubMed |
| Sister chromatid exchanges induced by perturbed replication can form independently of BRCA1, BRCA2 and RAD51. | Nat Commun | 2022 | 36344511 | PubTator, text mining | PubMed |
| Familial history and prevalence of BRCA1, BRCA2 and TP53 pathogenic variants in HBOC Brazilian patients from a public healthcare service. | Sci Rep | 2022 | 36329109 | PubTator, text mining | PubMed |
| BAP1 in cancer: epigenetic stability and genome integrity. | Discov Oncol | 2022 | 36318367 | PubTator, text mining | PubMed |
| The targets of aspirin in bladder cancer: bioinformatics analysis. | BMC Urol | 2022 | 36316768 | PubTator, text mining | PubMed |
| Urinary Biomarkers for the Noninvasive Detection of Gastric Cancer. | J Gastric Cancer | 2022 | 36316107 | PubTator, text mining | PubMed |
| Overlapping gene dependencies for PARP inhibitors and carboplatin response identified by functional CRISPR-Cas9 screening in ovarian cancer. | Cell Death Dis | 2022 | 36307400 | PubTator, text mining | PubMed |
| Genomic Biomarker Heterogeneities between SARS-CoV-2 and COVID-19. | Vaccines (Basel) | 2022 | 36298522 | PubTator, text mining | PubMed |
| Sensitivities and Dependencies of BRAF Mutant Colorectal Cancer Cell Lines with or without PIK3CA Mutations for Discovery of Vulnerabilities with Therapeutic Potential. | Medicina (Kaunas) | 2022 | 36295658 | PubTator, text mining | PubMed |
| Alterations in Homologous Recombination-Related Genes and Distinct Platinum Response in Metastatic Triple-Negative Breast Cancers: A Subgroup Analysis of the ProfiLER-01 Trial. | J Pers Med | 2022 | 36294734 | PubTator, text mining | PubMed |
| The Manufacture of Xeno- and Feeder-Free Clinical-Grade Human Embryonic Stem Cell Lines: First Step for Cell Therapy. | Int J Mol Sci | 2022 | 36293356 | PubTator, text mining | PubMed |
| Ubiquitin Proteasome Gene Signatures in Ependymoma Molecular Subtypes. | Int J Mol Sci | 2022 | 36293188 | PubTator, text mining | PubMed |
| Increased Risk of Hereditary Prostate Cancer in Italian Families with Hereditary Breast and Ovarian Cancer Syndrome Harboring Mutations in BRCA and in Other Susceptibility Genes. | Genes (Basel) | 2022 | 36292577 | PubTator, text mining | PubMed |
| Hereditary Breast and Ovarian Cancer Service in Sparsely Populated Western Pomerania. | Healthcare (Basel) | 2022 | 36292468 | PubTator, text mining | PubMed |
| The Mechanistic Roles of Sirtuins in Breast and Prostate Cancer. | Cancers (Basel) | 2022 | 36291902 | PubTator, text mining | PubMed |
| Application of Multigene Panels Testing for Hereditary Cancer Syndromes. | Biology (Basel) | 2022 | 36290365 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/580/papers?page=43